President Trump is poised to announce a sweeping new set of tariffs, aiming to restructure global trade and boost domestic manufacturing. This move has the potential to impact various industries, even those seemingly unconnected to traditional trade dynamics like the cosmetic and weight loss markets. 2024 data from the US Trade Census revealed that pharmaceutical imports from the EU were the most significant in value, underscoring the high dependence of American consumers on European pharmaceuticals. The EU’s pharmaceutical industry faces potential tariffs, posing challenges for companies producing popular medications like semaglutide (Ozempic and Wegovy) and other essential drugs.